肺静脉隔离治疗心房颤动。

F. Scazzuso, S. Rivera, V. Sammartino, G. Albina, R. Laiño, A. Giniger
{"title":"肺静脉隔离治疗心房颤动。","authors":"F. Scazzuso, S. Rivera, V. Sammartino, G. Albina, R. Laiño, A. Giniger","doi":"10.7775/RAC.80.1.789","DOIUrl":null,"url":null,"abstract":"Between March 2009 and December 2010, 94 consecutive procedures of pulmonary vein isolation were performed for treatment of paroxysmal and persistent atrial fibrillation. These interventions constitute the initial experience of the Instituto Cardiovascular de Buenos Aires , where 260 procedures are currently performed each year. Our population consisted mainly of men with an average age of 55.58 years; 71.9% had no history of cardiovascular disease. Paroxysmal atrial fibrillation occurred in 65.3% of cases over an average of 7 years. All patients had received three different antiarrhythmic agents excluding beta blockers or calcium channel antagonists. The average number of episodes of atrial fibrillation was 6 per year. The success rate during the procedure was 97.87%. The primary success rate at 12 months was 84.04%, 88.32% for the group without heart disease and 64.8% for the group with heart disease. Mean follow-up was 18±6 months. In our experience, pulmonary vein isolation is a treatment strategy for very selective cases with an acceptable primary success rate.","PeriodicalId":87148,"journal":{"name":"Technology Evaluation Center Assessment Program. Executive summary","volume":"34 1","pages":"1-3"},"PeriodicalIF":0.0000,"publicationDate":"2012-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Pulmonary vein isolation for treatment of atrial fibrillation.\",\"authors\":\"F. Scazzuso, S. Rivera, V. Sammartino, G. Albina, R. Laiño, A. Giniger\",\"doi\":\"10.7775/RAC.80.1.789\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Between March 2009 and December 2010, 94 consecutive procedures of pulmonary vein isolation were performed for treatment of paroxysmal and persistent atrial fibrillation. These interventions constitute the initial experience of the Instituto Cardiovascular de Buenos Aires , where 260 procedures are currently performed each year. Our population consisted mainly of men with an average age of 55.58 years; 71.9% had no history of cardiovascular disease. Paroxysmal atrial fibrillation occurred in 65.3% of cases over an average of 7 years. All patients had received three different antiarrhythmic agents excluding beta blockers or calcium channel antagonists. The average number of episodes of atrial fibrillation was 6 per year. The success rate during the procedure was 97.87%. The primary success rate at 12 months was 84.04%, 88.32% for the group without heart disease and 64.8% for the group with heart disease. Mean follow-up was 18±6 months. In our experience, pulmonary vein isolation is a treatment strategy for very selective cases with an acceptable primary success rate.\",\"PeriodicalId\":87148,\"journal\":{\"name\":\"Technology Evaluation Center Assessment Program. Executive summary\",\"volume\":\"34 1\",\"pages\":\"1-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Technology Evaluation Center Assessment Program. Executive summary\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7775/RAC.80.1.789\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Technology Evaluation Center Assessment Program. Executive summary","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7775/RAC.80.1.789","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

摘要

2009年3月至2010年12月,94例连续肺静脉隔离治疗阵发性和持续性心房颤动。这些干预措施构成了布宜诺斯艾利斯心血管研究所的初步经验,该研究所目前每年实施260例手术。本组人口以男性为主,平均年龄55.58岁;71.9%无心血管病史。平均7年发作性心房颤动发生率为65.3%。所有患者均接受了三种不同的抗心律失常药物治疗,不包括受体阻滞剂或钙通道拮抗剂。平均每年房颤发作次数为6次。手术成功率为97.87%。12个月的一次成功率为84.04%,无心脏病组为88.32%,有心脏病组为64.8%。平均随访18±6个月。根据我们的经验,肺静脉隔离是一种非常有选择性的病例的治疗策略,具有可接受的初级成功率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Pulmonary vein isolation for treatment of atrial fibrillation.
Between March 2009 and December 2010, 94 consecutive procedures of pulmonary vein isolation were performed for treatment of paroxysmal and persistent atrial fibrillation. These interventions constitute the initial experience of the Instituto Cardiovascular de Buenos Aires , where 260 procedures are currently performed each year. Our population consisted mainly of men with an average age of 55.58 years; 71.9% had no history of cardiovascular disease. Paroxysmal atrial fibrillation occurred in 65.3% of cases over an average of 7 years. All patients had received three different antiarrhythmic agents excluding beta blockers or calcium channel antagonists. The average number of episodes of atrial fibrillation was 6 per year. The success rate during the procedure was 97.87%. The primary success rate at 12 months was 84.04%, 88.32% for the group without heart disease and 64.8% for the group with heart disease. Mean follow-up was 18±6 months. In our experience, pulmonary vein isolation is a treatment strategy for very selective cases with an acceptable primary success rate.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Special Report: Chromosomal Microarray for the Genetic Evaluation of Patients With Global Developmental Delay, Intellectual Disability, and Autism Spectrum Disorder. Bronchial thermoplasty for treatment of inadequately controlled severe asthma. Special report: medication adherence. Special report: early intensive behavioral intervention and other behavioral interventions for autism spectrum disorder. Gene expression analysis for prostate cancer management.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1